The Latest Breaking News from Vaccine

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s (NASDAQ:BLUE) lead asset ZYNTEGLO (betibeglogene autotemcel) to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who require regular red blood cell (RBC) transfusions. Bluebird shares traded in a range of $6.13 to $8.18 on a day…

Academics in Canada looked at data on 85,162 births where half of the mothers had received a coronavirus vaccine during pregnancy.

The Joint Committee on Vaccination and Immunisation has confirmed which vaccines are appropriate for the autumn booster following the new dual variant vaccine that targets Omicron and original variant.

Some areas could be without jabs for three to four weeks

India today is double dosing every citizen and produced COVID-19 vaccines even during the lockdown period, said Union Finance Minister Nirmala Sitharaman

CNBC BlackRock To Pledge A$1B In Australian Battery Storage Assets – Report

The former Morrison government's planning for Australia's COVID-19 vaccine rollout was not "timely", it underestimated how difficult it would be to protect aged care and disability residents and failed to adequately engage with the states and territories before the rollout began, a damning review has found.

‘Even having had Omicron, we’re not well protected from further infections,’ said Prof Danny Altmann

Dame Jenny Harries said there are now around 20 cases a day, compared to 35 two weeks ago.

The country is facing "a very significant and growing problem" with Long Covid, according to TD